Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70% stenotic coronary artery disease: A case-control study

Atherosclerosis

Volumn 124, Issue 2, 1996, Pages 221-235

  Meyer, Ellen ^a   Westerveld, H Tineke ^a   De Ruyter Meijstek, Florianne C ^a   Van Greevenbroek, Marleen M J ^a   Rienks, Rienk ^b   Van Rijn, Herman J M ^c   Erkelens, D Willem ^a   De Bruin, Tjerk W A ^a  

^a Academic Hospital G02228   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c Dept Obstet Gynaecol Acad H   (Netherlands)

Author keywords

Apolipoprotein B 48; Coronary artery disease; Intermediate density lipoproteins; Retinyl palmitate; Very low density lipoproteins; Women

Indexed keywords

APOLIPOPROTEIN B48; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL;

EID: 0030564992     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(96)05832-7     Document Type: Article

References (62)

1. [1] Kuhn FE. Rackley CE. Coronary heart disease in women. Arch Intern Med 1993;153:2626-2636.
2. [2] Netherlands Central Bureau of Statistics. Mortality by main causes of death 1970-1990. SDU/Uitgeverij, 's Gravenhage. 1992; 19.
3. [3] Kannel WB. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study. Am Heart J 1987;114:413-419.
4. [4] Schaefer EJ, Lamon-Fava S, Conn SD, Schaefer MM, Ordovas JM, Castelli WP, Wilson PWF. Effects of age, gender and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring study. J Lipid Res 1994;35:779-792.
5. [5] Gordon DJ, Probstfield JE, Garrison RJ, Neaton JD. Castelli WP, Knoke JD, Jacobs DR, Bangdiwala S, Tyroler HA. High-density lipoprotein cholesterol and cardiovascular disease. Circulation 1989;79:8-15.
6. [6] Ueland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease and drug therapy. J Lab Clin Med 1989;114:473-501.
7. [7] Garber AM, Avins LA. Triglyceride concentration and coronary artery disease. Br Med J 1994;309:2-3.
8. [8] Austin MA. Triglycerides, small dense LDL, and coronary heart disease. Atherosclerosis 1994;109:259.
9. [9] Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: The Framingham Study. Ann Intern Med 1976;85:447-452.
10. [10] Colditz GA, Willett WC, Stampfer M, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987;316:1105-1110.
11. [11] Rosenberg L, Hennekens CH, Rosner B, Belanger C, Rothman KJ, Speizer FE. Early menopause and the risk of myocardial infarction. Am J Obstet Gynecol 1981;139:47-51.
12. [12] Bengtsson C, Rybo G, Westerberg H. Number of pregnancies, use of oral contraceptives and menopausal age in women with ischaemic heart disease, compared to a population sample of women. In: Ischaemic Heart Disease in Women. C Bengtsson, editor. Elanders Boktryckeri Aktiebolag Kungsbacka, Goteborg. 1973:75-91.
13. [13] Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation 1979;60:473-485.
14. [14] Patsch JS, Miesenböck G, Hopferwieser T, Muhlberger V, Knapp E, Dunn JK, Gotto AM, Patsch W. Relation of triglyceride metabolism and coronary artery disease. Arterioscler Thromb 1992;12:1336-1345.
15. [15] Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis (106) 1994:83-97.
16. [16] Goldstein JL, Brown MS, Innerarity TL, Mahley RW. Cholesterol ester accumulation in macrophages resulting from receptor-mediated uptake and degradation of hypercholesterolemic canine β-very low density lipoproteins. J Biol Chem 1980;255:1839-1848.
17. [17] Van Lenten BJ, Fogelman AM, Jackson RL, Shapiro S, Haberland ME, Edwards PA. Receptor-mediated uptake of remnant lipoproteins by cholesterol loaded human monocyte-macrophages. J Biol Chem 1985;260:8783 8788.
18. [18] Floren CH, Albers JJ, Bierman EL. Uptake of chylomicron remnants causes cholesterol accumulation in cultured human arterial smooth muscle cells. Biochim Biophys Acta 1981;663:336-349.
19. [19] Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, Wissler RW. American Heart Association Medical/Scientific Statement. A definition of initial, fatty streak and intermediate lesions of atherosclerosis. Arterioscler Thromb 1994;14:840-856.
20. [20] Phillips NR, Waters D, Havel RJ. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 1993;88:2762-2770.
21. [21] Simpson HS, Williamson CM, Olivecrona T, Pringle S, Maclean J, Lorimer AR, Bonnefous F, Bogaievsky F, Packard CJ, Shepherd J. Postprandial lipemia, fenofibrate and coronary artery disease. Atherosclerosis 1990;85:193-202.
22. [22] Groot PHE, van Stiphout WAHJ, Krauss XH, Jansen H, van Tol A, van Ramshorst E, Chin-On S, Hofman A, Cresswell SR, and Havekes L. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 1991;11:653-662.
23. [23] Karpe F, Steiner G, Olivecrona T, Carlson LA, Hamsten A. Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. J Clin Invest 1993;91:748-758.
24. [24] Syvanne M, Hilden H, Taskinen MR. Abnormal metabolism of postprandial lipoproteins in patients with non-insulin-dependent diabetes mellitus is not related to coronary artery disease. J Lipid Res 1994;35:15-26.
25. [25] Ginsberg HN, Jones J, Blaner WS, Thomas A, Karmally W, Fields L, Blood D, Begg MD. Association of postprandial triglyceride and palmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle-aged men and women. Arterioscler Thromb Vasec Biol 1995;15:1829-1838.
26. [26] Verschuren WMM, van Leer EM, Blokstra A, Seidell JC, Smit HA, Bueno de Mesquita HB, Obermann-de Boer GL, Kromhout D. Cardiovascular disease risk factors in the Netherlands. Neth J Cardiol 1993;4:205-210.
27. [27] Weintraub MS, Eisenberg S, Breslow JL. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest 1987;80:1571-1577.
28. [28] Castro Cabezas M, de Bruin TWA, Jansen H, Kock LAW, Kortlandt W, Erkelens DW. Impaired chylomicron remnant clearance in familial combined hyperlipidemia. Arterioscler Thromb 1993;13:804-814.
29. [29] de Bruin TWA, Brouwer CB, Gimpel JA, Erkelens DW. Postprandial decrease in HDL cholesterol and HDL apo A-I in normal subjects in relation to triglyceride metabolism. Am J Physiol 260 (1991) E492-E498.
30. [30] Redgrave TG, Roberts DCK, West CE. Separation of plasma lipoproteins by density gradient ultracentrifugation. Anal Biochem 1975;65:42-49.
31. [31] Gidez LI, Miller GJ, Burstein M, Slagle S, Eder HA. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res 1982;23:1206-1223.
32. [32] Simpson HS, Ballantyne FC, Packard CJ, Morgan HG, Shepherd J. High-density lipoprotein subfractions as measured by differential polyanionic precipitation and rate zonal ultracentrifugation. Clin Chem 1982;28:2040-2043.
33. [33] Jansen H, Hop W, van Tol A, Bruschke AVG, Birkenhager JC. Hepatic lipase and lipoprotein lipase are not major determinants of the low density lipoprotein subclass pattern in human subjects with coronary artery disease. Atherosclerosis 1994;107:45-54.
34. [34] Huttunen JK, Ehnholm C, Kinnunen PKJ, Nikkila EA. An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma. Clin Chim Acta 1975;63:335-347.
35. [35] Dallinga-Thie GM, Kock LAW, de Bruin TWA. Apolipoprotein E2/E3/E4 genotyping using agarose gels. Clin Chem 1995;41:73-75.
36. [36] Westerveld HE, Kock LAW, van Rijn HJM, Erkelens DW, de Bruin TWA. 17β-estradiol improves postprandial lipid metabolism in postmenopausal women. J Clin Endocrinol Med 1995;80:249-253.
37. [37] Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high performance liquid chromatography with fluorescence detection. J Chromatogr Biomed Appl 1987;422:43-52.
38. [38] Brown SA, Hutchinson R, Morrisett J, Boerwinkle E, Davis CE, Gotto AM, Patsch WP. Plasma lipid, lipoprotein cholesterol and apoprotein distributions in selected US communities. The ARIC study. Arterioscler Thromb 1993;13:1139-1158.
39. [39] Prichard BN, Owens CW, Woolf AS. Adverse reactions to diuretics. Eur Heart J 1992;13(Suppl. G):96-103.
40. [40] Kannel WB, Castelli WP, Gordon T, McNamara P. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. Ann Intern Med 1971;74:1-12.
41. [41] Sacks FM, Campos H, Walsh BW, Yang X-Y, Li H. Postprandial metabolism of human plasma lipoproteins of intestinal and hepatic origin determined by endogenous labeling. Circulation 1995;92(Suppl.) I-157.
42. [42] Redgrave TG, Carlson LA. Changes in plasma very low density and low density lipoprotein content, composition and size after a fatty meal in normo- and hypertriglyceridemic man. J Lipid Res 1979;20:217-229.
43. [43] Berr F. Characterization of chylomicron remnant clearance by retinyl palmitate label in normal humans. J Lipid Res 1992;33:915-930.
44. [44] Karpe F, Bell M, Björkegren J, Hamsten A. Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurements of apolipoproteins B-48 and apo B-100. Arterioscler Thromb Vasc Biol 1995;15:8342-8436.
45. [45] Hultin M, Carneheim C, Rosenqvist K, Olivecrona T. Intravenous lipid emulsions: removal mechanisms as compared to chylomicrons. J Lipid Res 1995;36:2174-2184.
46. [46] Scott J, Navaratnam N, Bhattacharya S, Morrison JR. The apolipoprotein B messenger RNA editing enzyme. Curr Opin Lipidol 1994;5:87-93.
47. [47] Sato R, Imanaka T, Takatsuki A, Takano T. Degradation of newly synthesized apo B-100 in a pre-Golgi compartment. J Biol Chem 1990;265:11880-11884.
48. [48] Davidson NO, Drewek MJ, Gordon JL, Elovson J. Rat intestinal apolipoprotein B gene expression. Evidence for integral regulation by bile salts, fatty acid and phospholipid flux. J Clin Invest 1988;82:300-308.
49. [49] Wetterau JR, Aggerbeck LP, Bouma ME. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science 1992;258:999-1001.
50. [50] Schneeman BO, Kotite L, Todd KM, Havel RJ. Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans. Proc Natl Acad Sci USA 1993;90:2069-2073.
51. [51] Cohn JS, Johnson EJ, Millar JS, Cohn SD, Milne RW, Marcel YL, Russell RM, Schaefer EJ. Contribution of apo B-48 and apo B-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters. J Lipid Res 1993;34:2033-2040.
52. [52] Wilson DE, Chan IF, Ball M. Plasma lipoprotein retinoids after vitamin A feeding in normal man: minimal appearance of retinyl esters among low density lipoproteins. Metabolism 1983;32:514-517.
53. [53] Krasinski SD, Cohn JS, Russell RM, Schaefer EJ. Postprandial plasma vitamin A metabolism in humans: a reassessment of the use of plasma retinyl esters as markers for intestinally derived chylomicrons and their remnants. Metabolism 1990;39:357-365.
54. [54] Blaner WS, Obunike JC, Kurlandsky SB, Al-Haideri M, Piantedosi R, Deckelbaum RJ, Goldberg IJ. Lipoprotein lipase hydrolysis of retinyl ester. J Biol Chem 1994;269:16559-16565.
55. [55] Havel RJ, Kane JP, Kashyap M. Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man. J Clin Invest 1973;52:32-38.
56. [56] Olivecrona T, Bengtsson-Olivecrona G, Ostergaard P, Liu G. Chevreuil O, Hultin M. New aspects on heparin and lipoprotein metabolism. Haemostasis 1993;23(S1):150-160.
57. [57] Groot PHE, Scheek LM, Jansen H. Liver lipase and high-density lipoprotein. Biochim Biophys Acta 1983;751:393-400.
58. [58] Sultan F, Lagrange D, Jansen H, Griglio S. Inhibition of hepatic lipase activity impairs chylomicron remnant removal in rats. Biochim Biophys Acta 1990;1041:150-152.
59. [59] Zambon A, Austin MA, Brown G, Hokanson JE, Brunzell JD. Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. Arterioscler Thromb 1992;13:147-153.
60. [60] Ebert DL, Warren RJ, Barter PJ, Mitchell A. Infusion of atherogenic lipoprotein particles increases hepatic lipase activity in the rabbit. J Lipid Res 1993;34:89-94.
61. 2 cholesterol subspecies and elevated postheparin hepatic lipase activity in older men with abdominal obesity and asymptomatic myocardial ischemia. Arterioscler Thromb 1992;12:814-823.
62. [62] Blades B, Vega GL, Grundy SM. Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol. Arterioscler Thromb 1993;13:1227-1235.